These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 28379653
1. Factors Related to Prostaglandin-Associated Periorbitopathy in Glaucoma Patients. Patradul C, Tantisevi V, Manassakorn A. Asia Pac J Ophthalmol (Phila); 2017; 6(3):238-242. PubMed ID: 28379653 [Abstract] [Full Text] [Related]
2. Proposal of a simple grading system integrating cosmetic and tonometric aspects of prostaglandin-associated periorbitopathy. Tanito M, Ishida A, Ichioka S, Takayanagi Y, Tsutsui A, Manabe K, Shirakami T, Sugihara K, Matsuo M. Medicine (Baltimore); 2021 Aug 27; 100(34):e26874. PubMed ID: 34449456 [Abstract] [Full Text] [Related]
3. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Kucukevcilioglu M, Bayer A, Uysal Y, Altinsoy HI. Clin Exp Ophthalmol; 2014 Mar 27; 42(2):126-31. PubMed ID: 23844550 [Abstract] [Full Text] [Related]
4. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension. Lin L, Zhao YJ, Chew PT, Sng CC, Wong HT, Yip LW, Wu TS, Bautista D, Teng M, Khoo AL, Lim BP. Ann Pharmacother; 2014 Dec 27; 48(12):1585-93. PubMed ID: 25184309 [Abstract] [Full Text] [Related]
5. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma. Mishra D, Sinha BP, Kumar MS. Korean J Ophthalmol; 2014 Oct 27; 28(5):399-407. PubMed ID: 25276082 [Abstract] [Full Text] [Related]
6. Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension. Heo JH, Rascati KL, Wilson JP, Lawson KA, Richards KM, Nair R. J Manag Care Spec Pharm; 2019 Sep 27; 25(9):1001-1010. PubMed ID: 31456491 [Abstract] [Full Text] [Related]
7. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues. El Ameen A, Vandermeer G, Khanna RK, Pisella PJ. Eur J Ophthalmol; 2019 Nov 27; 29(6):645-653. PubMed ID: 30301370 [Abstract] [Full Text] [Related]
8. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study. Reardon G, Schwartz GF, Mozaffari E. Clin Ther; 2003 Apr 27; 25(4):1172-85. PubMed ID: 12809964 [Abstract] [Full Text] [Related]
9. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials. Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J. Br J Ophthalmol; 2009 Mar 27; 93(3):316-21. PubMed ID: 19019922 [Abstract] [Full Text] [Related]
10. Periorbital changes associated with prostaglandin analogs in Korean patients. Kim HW, Choi YJ, Lee KW, Lee MJ. BMC Ophthalmol; 2017 Jul 17; 17(1):126. PubMed ID: 28716077 [Abstract] [Full Text] [Related]
12. Shortening of Interpupillary Distance after Instillation of Topical Prostaglandin Analog Eye Drops. Sano I, Takahashi H, Inoda S, Sakamoto S, Arai Y, Takahashi Y, Ohkubo A, Kawashima H, Mayama C. Am J Ophthalmol; 2019 Oct 17; 206():11-16. PubMed ID: 30902695 [Abstract] [Full Text] [Related]